What Is CJC-1295? A Clear Look at the GHRH Analog Research Peptide

Quick answer: What is CJC? In research contexts, CJC-1295, often referred to simply as CJC, is a synthetic, long-acting analog of growth hormone-releasing hormone (GHRH). It has been extensively studied for its ability to produce sustained increases in growth hormone and IGF-1 levels in research settings.

Among research peptides, CJC-1295 is one of the most studied compounds in growth hormone research, often mentioned alongside ipamorelin. This article provides a clear look at what CJC is, its research applications, and key considerations for sourcing it.

What is CJC-1295?

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). [1] Research indicates this CJC peptide was studied as a long-acting GHRH analog, designed to mimic the natural hormone's action. [2] In studies, CJC produced sustained increases in growth hormone and IGF-1 levels and demonstrated a much longer half-life than the natural hormone, with observed effects lasting several days after a single administration (Teichman et al., 2005, DOI).

Why the long-acting part matters in research

Natural GHRH breaks down quickly within the body, which limits how its sustained effects can be studied. [1] The CJC-1295 peptide drew significant research interest because it exhibits a far longer duration of action, a key focus of published work. [1] This extended duration is a defining feature of the CJC compound and a primary reason for its frequent appearance in growth hormone research literature.

How it relates to ipamorelin

CJC-1295 acts on the GHRH receptor pathway. [3] Ipamorelin acts on a different pathway, the ghrelin or GHRP receptor. [1] Because the two peptides work through different routes, they are often studied together, which is why a CJC-1295 and Ipamorelin blend exists as a single research product. For the full breakdown, see our Ipamorelin vs CJC-1295 comparison.

Sourcing CJC-1295

When sourcing any research peptide like CJC-1295, or any CJC variant, robust documentation is crucial for ensuring product integrity and supporting research validity. Researchers should look for a per-batch Certificate of Analysis (COA) available for review before purchase, along with HPLC purity data specific to the lot, mass spectrometry confirmation, and a lot number clearly tied to the vial. For more information on verifying vendors, see our guide on How to Verify a Research Peptide Vendor.

Peptide Hackers carries CJC-1295, along with the CJC-1295 and Ipamorelin blend, and other CJC peptides, with that documentation on every batch. For researchers in the Los Angeles and Orange County areas, you can order online and pick up the same day in person, with shipping available if you prefer delivery. The full catalog is at peptidehackers.com.

All products are for laboratory research only. Not for human or veterinary use.

What is a Peptide?

Peptides are short chains of amino acids linked by peptide bonds. They are distinct from proteins, which are typically longer chains. The specific sequence and three-dimensional shape of a peptide can determine its biological role in research. Researchers study many different types of peptides, including linear, cyclic, and branched forms, to understand their potential applications. For example, BPC-157 and TB-500 are two well-known research peptides.

Emerging Research Directions in Peptide Science

The field of peptide research is continually evolving, with new synthesis methods and applications under investigation. Recent studies have explored the potential of cyclic peptides, which possess constrained molecular structures that may offer improved stability and binding characteristics compared to their linear counterparts. Another area of interest is peptide-drug conjugates, which are being investigated as targeted delivery platforms for various research compounds. Advances in peptide synthesis, drawing inspiration from natural processes, also promise to enable the creation of more complex and diverse peptide structures for future studies.

Frequently Asked Questions

What is the difference between a peptide and a protein?

While both peptides and proteins are composed of amino acids linked by peptide bonds, the primary distinction lies in their size. Peptides are generally shorter chains of amino acids, typically up to 50 amino acids, whereas proteins are longer, more complex structures. The true functional difference often relates to their folding and structural complexity.

What is peptide synthesis?

Peptide synthesis refers to the process of creating peptides by linking amino acids in a specific sequence. Historically, this involved classical solution-phase techniques, but modern research and development settings often utilize more advanced solid-phase synthesis methods to achieve higher purity and efficiency.

What is the significance of cyclic peptides in research?

Cyclic peptides are attracting significant research interest due to their constrained molecular structure. This unique conformation can potentially improve their stability against enzymatic degradation and enhance their binding characteristics to target molecules, making them valuable for investigating new research applications.

What is a GHRH analog?

A GHRH analog, such as CJC-1295, is a synthetic compound designed to mimic the action of natural Growth Hormone Releasing Hormone (GHRH). These analogs are often engineered to have a longer half-life or altered binding properties, allowing researchers to study sustained effects on growth hormone secretion.

Is CJC-1295 the same as HGH?

No, CJC-1295 is not the same as Human Growth Hormone (HGH). CJC-1295 is classified as a growth hormone-releasing hormone (GHRH) analog. Its mechanism of action involves stimulating the pituitary gland to release its own growth hormone. In contrast, HGH refers to the exogenous administration of growth hormone itself. Researchers study CJC-1295 to understand how it influences the body's natural growth hormone secretion pathways, rather than directly introducing growth hormone.

What are the observed effects of CJC-1295 in research?

Information regarding "side effects" typically pertains to human clinical trials and medical applications, which are outside the scope of research-use-only peptides. In laboratory research settings, studies focus on the mechanisms of action and observed physiological responses of CJC-1295, such as its ability to increase growth hormone and IGF-1 levels. Researchers are encouraged to consult primary scientific literature for detailed observations from specific studies.

Does CJC-1295 influence testosterone levels?

Current research on CJC-1295 primarily focuses on its role as a growth hormone-releasing hormone (GHRH) analog and its observed effects on growth hormone and IGF-1 levels. While growth hormone and testosterone can interact in complex biological systems, direct evidence from research specifically linking CJC-1295 to a primary increase in testosterone levels is not a central focus of the existing literature. Researchers interested in testosterone regulation typically investigate other specific pathways and compounds.

CJC-1295 with DAC vs. Without DAC

Researchers often encounter two forms of CJC-1295: with DAC (Drug Affinity Complex) and without DAC. The DAC modification is a key feature that distinguishes these two research peptides. CJC-1295 with DAC is designed to bind to serum albumin, which significantly extends its half-life and allows for a more sustained release of growth hormone-releasing hormone (GHRH) activity. This extended action is a primary reason for its study in contexts requiring prolonged effects.

In contrast, CJC-1295 without DAC, often referred to as Mod GRF 1-29, has a much shorter half-life, similar to natural GHRH. While both compounds stimulate growth hormone release, their pharmacokinetic profiles differ substantially due to the presence or absence of the DAC. Researchers select between these forms based on the desired duration of action for their specific experimental protocols.

Research Applications of CJC-1295

The sustained elevation of growth hormone and IGF-1 levels observed with CJC-1295 has led to its investigation across various research applications. Studies have explored its potential in understanding metabolic processes, particularly how sustained growth hormone release might influence glucose regulation and lipid metabolism in different models.

Another area of research involves the study of tissue repair and regeneration. Growth hormone is known to play a role in cellular proliferation and differentiation, and researchers are examining how CJC-1295's action might contribute to these processes. Furthermore, some preclinical studies have touched upon its influence on aspects of body composition, observing changes in lean mass or fat distribution in animal models, though these findings require further investigation to fully characterize the mechanisms involved. The long-acting nature of CJC-1295 with DAC makes it particularly suitable for studies requiring prolonged physiological effects.

What does CJC peptide do in research?

In research settings, CJC-1295 (a CJC peptide) is primarily studied for its role as a growth hormone-releasing hormone (GHRH) analog. Its main observed action is to stimulate the pituitary gland to release endogenous growth hormone. This leads to sustained increases in both growth hormone and insulin-like growth factor 1 (IGF-1) levels. Researchers investigate these effects to understand potential applications in areas related to growth, metabolism, and tissue repair, always within a controlled laboratory environment.

Can CJC-1295 influence body composition or weight?

Research into CJC-1295 primarily focuses on its effects on growth hormone and IGF-1 levels. While these hormones are known to play roles in metabolism and potentially influence body composition, direct research specifically on CJC-1295 causing "weight gain" in a general sense is not a primary focus of the existing scientific literature. Studies typically investigate its impact on lean mass or fat mass in specific research models. Researchers interested in the broader effects on body weight or composition would need to consult studies specifically designed to evaluate these outcomes.

References

1. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives — Int J Mol Sci (2026). PMID: 42123471
2. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — J Clin Endocrinol Metab (2006). PMID: 16352683
3. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging — Front Aging (2026). PMID: 42021992